Stocks and Investing
Stocks and Investing
Fri, July 31, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Patrick Donnelly Maintained (BIO) at Strong Buy with Increased Target to $625 on, Jul 31st, 2020
Patrick Donnelly of Citigroup, Maintained "Bio-Rad Laboratories, Inc." (BIO) at Strong Buy with Increased Target from $525 to $625 on, Jul 31st, 2020.
Patrick has made no other calls on BIO in the last 4 months.
There is 1 other peer that has a rating on BIO. Out of the 1 peers that are also analyzing BIO, 0 agree with Patrick's Rating of Hold.
This is the rating of the analyst that currently disagrees with Patrick
- Dan Leonard of "Wells Fargo" Maintained at Buy with Increased Target to $525 on, Thursday, May 21st, 2020